{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:10:08Z","timestamp":1790187008795,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016226","name":"Accuray","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5x1000"],"award-info":[{"award-number":["5x1000"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpt.2026.101963","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:06:01Z","timestamp":1789398361000},"page":"101963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reirradiation With Proton Therapy Using Hypofractionated Schedules: A Systematic Review of the Literature"],"prefix":"10.1016","volume":"22","author":[{"given":"Daniela","family":"Alterio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Eleonora","family":"Pierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Vincini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvaso","family":"Giulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mastroleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Kube\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Nieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101963_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5306\/wjco.v13.i4.237","article-title":"GOECP\/SEOR radiotheraphy guidelines for non-small-cell lung cancer","volume":"13","author":"Rodr\u00edguez De Dios","year":"2022","journal-title":"World J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101963_bib3","first-page":"1144","article-title":"Hypofractionated radiotherapy in localized, low-intermediate-risk prostate cancer: current and future prospectives","volume":"59","author":"Lo Greco","year":"2023","journal-title":"Med (Kaunas)"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18053\/jctres.07.202102.017","article-title":"Hypofractionation and stereotactic body radiation therapy in inoperable locally advanced non-small cell lung cancer","volume":"7","author":"Rico","year":"2021","journal-title":"J Clin Transl Res"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101963_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2022.02.009","article-title":"How low can you go? The radiobiology of hypofractionation","volume":"34","author":"Brand","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib6","article-title":"Thoracic reirradiation for lung cancer: a literature review and practical guide","volume":"3","author":"Drodge","year":"2014","journal-title":"Ann Palliat Med"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101963_bib7","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.21873\/anticanres.16377","article-title":"Moderately hypofractionated radio(chemo)therapy with simultaneous integrated boost for recurrent, previously irradiated, high-grade glioma","volume":"43","author":"Graen","year":"2023","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2017.11.036","article-title":"Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: a multi-institution analysis","volume":"100","author":"Caudell","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"10380","key":"10.1016\/j.ijpt.2026.101963_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(23)00269-6","article-title":"Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"401","author":"You","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijpt.2026.101963_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104114","article-title":"Hypofractionated proton therapy for benign tumors of the central nervous system: a systematic review of the literature","volume":"191","author":"Piperno","year":"2023","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.ijpt.2026.101963_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102464","article-title":"Hypofractionated proton therapy for non-small cell lung cancer: ready for prime time? A systematic review and meta-analysis","volume":"110","author":"Volpe","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-022-06516-4","article-title":"Hypofractionated proton therapy in breast cancer: Where are we? A critical review of the literature","volume":"192","author":"Alterio","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101963_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cancers14092271","article-title":"The role of hypofractionation in proton therapy","volume":"14","author":"Santos","year":"2022","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.ijpt.2026.101963_bib14","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.3390\/cancers15184571","article-title":"5-years analysis of effectivity and toxicity of ultra-hypofractionated proton radiotherapy in the treatment of low- and intermediate-risk prostate cancer-a retrospective analysis","volume":"15","author":"Kube\u0161","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2017.08.005","article-title":"Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation","volume":"125","author":"Verma","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101963_bib17","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5603\/RPOR.a2021.0029","article-title":"Proton re-irradiation of unresectable recurrent head and neck cancers","volume":"26","author":"Gordon","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13014-019-1407-9","article-title":"The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine","volume":"14","author":"Guan","year":"2019","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101963_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00066-017-1129-6","article-title":"Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy","volume":"193","author":"Yamazaki","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101963_bib21","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.21873\/anticanres.11132","article-title":"Comparison of re-irradiation outcomes for charged particle radiotherapy and robotic stereotactic radiotherapy using CyberKnife for recurrent head and neck cancers: a multi-institutional matched-cohort analysis","volume":"36","author":"Hideya","year":"2016","journal-title":"AR"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4143\/crt.2020.1349","article-title":"Re-irradiation with Moderate hypo-fractionation using intensity modulated photon or proton radiation therapy in locally recurrent squamous cell carcinoma of nasopharynx","volume":"54","author":"Nam","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101963_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.prro.2019.02.008","article-title":"Clinical outcomes of patients with recurrent lung cancer reirradiated with proton therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies","volume":"9","author":"Badiyan","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/life12020292","article-title":"Toxicity of proton therapy versus photon therapy on salvage re-irradiation for non-small cell lung cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ijpt.2026.101963_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1074675","article-title":"Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era","volume":"12","author":"Janopaul-Naylor","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2005.11.043","article-title":"Repeated proton beam therapy for hepatocellular carcinoma","volume":"65","author":"Hashimoto","year":"2006","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2017.03.004","article-title":"Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma","volume":"123","author":"Oshiro","year":"2017","journal-title":"Radiother Oncol"},{"issue":"Supplement_1","key":"10.1016\/j.ijpt.2026.101963_bib28","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/jrr\/rrad024","article-title":"Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review","volume":"64","author":"Murayama","year":"2023","journal-title":"J Radiat Res"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101963_bib29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2005.09.035","article-title":"Conservation treatment of the eye: conformal proton reirradiation for recurrent uveal melanoma","volume":"64","author":"Marucci","year":"2006","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2009.12.018","article-title":"Uveal Melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation","volume":"79","author":"Marucci","year":"2011","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101963_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajo.2014.07.013","article-title":"Salvage proton beam therapy in local recurrent uveal melanoma","volume":"158","author":"Riechardt","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib32","first-page":"970","article-title":"Proton re-irradiation of unresectable recurrent brain gliomas: clinical outcomes and toxicity","volume":"26","author":"Gulidov","year":"2021","journal-title":"J BUON"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101963_bib33","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.adro.2020.03.022","article-title":"Clinical outcomes in patients with recurrent glioblastoma treated with proton beam therapy reirradiation: analysis of the Multi-Institutional Proton Collaborative Group Registry","volume":"5","author":"Saeed","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101963_bib34","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0360-3016(93)90067-6","article-title":"The tolerance of primate spinal cord to re-irradiation","volume":"25","author":"Ang","year":"1993","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2015.02.021","article-title":"Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: a multi-institutional matched-cohort analysis","volume":"115","author":"Yamazaki","year":"2015","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2017.11.045","article-title":"Carotid dosimetry and the risk of carotid blowout syndrome after reirradiation with head and neck stereotactic body radiation therapy","volume":"101","author":"Gebhardt","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.ijpt.2026.101963_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1748-717X-8-242","article-title":"A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers","volume":"8","author":"Yazici","year":"2013","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2013.08.012","article-title":"Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer","volume":"109","author":"Lartigau","year":"2013","journal-title":"Radiother Oncol"},{"issue":"22","key":"10.1016\/j.ijpt.2026.101963_bib40","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/cncr.28934","article-title":"Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial","volume":"120","author":"Tian","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijpt.2026.101963_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103088","article-title":"Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach","volume":"155","author":"Alterio","year":"2020","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.ijpt.2026.101963_bib42","article-title":"Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy","volume":"10","author":"Xiao","year":"2015","journal-title":"PLoS ONE"},{"issue":"30","key":"10.1016\/j.ijpt.2026.101963_bib43","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"JCO"},{"key":"10.1016\/j.ijpt.2026.101963_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for ultra-central lung tumors: a systematic review and meta-analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib45","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.cllc.2020.05.010","article-title":"Ultra-central thoracic re-irradiation using 10-fraction stereotactic body radiotherapy for recurrent non\u2013small-cell lung cancer tumors: preliminary toxicity and efficacy outcomes","volume":"22","author":"Sood","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101963_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/COC.0000000000000709","article-title":"Effectiveness and safety of reirradiation with stereotactic ablative radiotherapy of lung cancer after a first course of thoracic radiation: a meta-analysis","volume":"43","author":"Viani","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"9666","key":"10.1016\/j.ijpt.2026.101963_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101963_bib48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ijpt.2026.101963_bib49","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1200\/JCO.2016.72.1464","article-title":"Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer","volume":"35","author":"Ikoma","year":"2017","journal-title":"JCO"},{"issue":"12","key":"10.1016\/j.ijpt.2026.101963_bib50","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1463-1318.2012.03005.x","article-title":"Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer","volume":"14","author":"Bhangu","year":"2012","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101963_bib51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/bjs.9569","article-title":"Feasibility of reirradiation in the treatment of locally recurrent rectal cancer","volume":"101","author":"Bosman","year":"2014","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101963_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2005.09.017","article-title":"Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study","volume":"64","author":"Valentini","year":"2006","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","article-title":"Reirradiation of locally recurrent rectal cancer: a systematic review","volume":"113","author":"Guren","year":"2014","journal-title":"Radiother Oncol"},{"issue":"14","key":"10.1016\/j.ijpt.2026.101963_bib54","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101963_bib55","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1245\/s10434-020-08362-4","article-title":"Improved outcomes for responders after treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer","volume":"27","author":"Voogt","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijpt.2026.101963_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.06.030","article-title":"A multicentre retrospective review of SABR reirradiation in rectal cancer recurrence","volume":"162","author":"Johnstone","year":"2021","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101963_bib57","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.adro.2020.07.017","article-title":"Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: outcomes and toxicity","volume":"5","author":"Smith","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-024-02555-x","article-title":"Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study","volume":"19","author":"Gambacorta","year":"2024","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/jcb.2019.82888","article-title":"Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review","volume":"11","author":"Tagliaferri","year":"2019","journal-title":"J Contemp Brachyther"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.brachy.2013.10.007","article-title":"Reirradiation of the eye with plaque brachytherapy: a single institution experience report of eight consecutive patients submitted to retreatment after local relapse of malignant disease of the eye","volume":"13","author":"Gaspar De Souza Neves","year":"2014","journal-title":"Brachytherapy"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101963_bib61","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.21873\/anticanres.11067","article-title":"Re-irradiation for recurrent primary brain tumors","volume":"36","author":"Nieder","year":"2016","journal-title":"AR"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clon.2017.11.006","article-title":"Re-irradiation in the brain: primary gliomas","volume":"30","author":"Ho","year":"2018","journal-title":"Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101963_bib63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The evolving role of reirradiation in the management of recurrent brain tumors","volume":"164","author":"De Pietro","year":"2023","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0360-3016(93)90428-X","article-title":"Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol","volume":"27","author":"Russell","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101963_bib66","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society Practice Guidelines","author":"Bae","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101963_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17474124.2020.1744434","article-title":"An overview of stereotactic body radiation therapy for hepatocellular carcinoma","volume":"14","author":"Kimura","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101963_bib68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.prro.2020.08.002","article-title":"Repeated stereotactic body radiation therapy for hepatocellular carcinoma","volume":"11","author":"Eriguchi","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101963_bib69","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.ijrobp.2020.07.034","article-title":"A multi-institutional retrospective study of repeated stereotactic body radiation therapy for intrahepatic recurrent hepatocellular carcinoma","volume":"108","author":"Kimura","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101963_bib70","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101963_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2020.09.033","article-title":"Radiotherapy treatment plannINg study Guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies","volume":"153","author":"Hansen","year":"2020","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101963_bib72","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of QUANTEC: recommendations for reporting and gathering data on dose\u2013volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol*Biol*Phys"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026006669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026006669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:53:27Z","timestamp":1790186007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518026006669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":72,"alternative-id":["S2331518026006669"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101963","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reirradiation With Proton Therapy Using Hypofractionated Schedules: A Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101963"}}